Click the headlines below to read the latest cancer news:

Removal of More Lymph Nodes May Improve Survival in Gastric and Pancreatic Cancers

07/23/2008

Researchers recommend that at least 15 lymph nodes be removed and examined in patients with early gastric or pancreatic cancers. These results were recently published in the Archives of Surgery.

Diagnostic Test Approved for Differentiating Between Types of Lung Cancer

07/23/2008

A diagnostic test using MicroRNA technology has received regulatory approval to differentiate between the two main types of non–small cell lung cancer: squamous and non-squamous cell. These results were recently released in a press release by Rosetta Genomics Ltd.

BiovaxID® Improves Disease-free Survival in Non-Hodgkin’s Lymphoma

07/21/2008

The personalized investigative vaccine BiovaxID® (personalized anti-idiotype vaccine) significantly improves cancer-free survival among patients with non-Hodgkin’s lymphoma. These results were released in a press release by Accentia BioPharmaceuticals.

Thickness of Squamous Cell Cancer Associated with Risk of Recurrences

07/18/2008

The thickness of squamous cell carcinoma (SCC) of the skin is directly related to the risk of recurrences. These results were recently published in Lancet Oncology.

Radiofrequency Ablation Effective for Lung Tumors

07/16/2008

The use of radiofrequency ablation for the treatment of lung cancer, or pulmonary metastases (cancer that has spread from site of origin to the lung) provides an effective and safe therapeutic option for some patients. These results were recently published in the Lancet Oncology.

Obesity with Depleted Muscle Mass Affects Mortality in Cancer Patients

07/16/2008

Sarcopenic obesity, or obesity with depleted muscle mass, affects distribution of chemotherapy and ultimately may significantly affect mortality among obese patients with cancer. These results were recently published in the Lancet Oncology.

Treanda® plus Rituxan® Effective for Recurrent Non-Hodgkin’s Lymphoma

07/15/2008

The treatment combination consisting of Treanda® (bendamustine) plus Rituxan® (rituximab) provides effective therapy for patients with non-Hodgkin’s lymphoma (NHL) that has stopped responding to prior treatment. These results were recently published in the Journal of Clinical Oncology.

Higher Vitamin D Levels Result in Better Survival Among Colorectal Cancer Patients

07/15/2008

Among patients diagnosed with colorectal cancer, those with higher levels of vitamin D in their blood prior to diagnosis have an improved survival compared with those with lower levels. These results were recently published in the Journal of Clinical Oncology.

Denosumab Improves Bone Density in Prostate Cancer Patients

07/14/2008

In a Phase III clinical trial among men receiving androgen-deprivation therapy for nonmetastatic prostate cancer, treatment with investigational drug denosumab improved bone density and reduced the risk of vertebral fractures.

Melanoma Rates Increasing in Young Women

07/11/2008

Rates of melanoma—the most deadly form of skin cancer—continue to increase among young women in the United States. These results were published in the Journal of Investigative Dermatology.

More cancer news...